S
Stockadora

GALAPAGOS NV

GLPG Nasdaq CIK: 0001421876

Company Information

Industry Pharmaceutical Preparations
SIC Code 2834
Entity Type other
SEC Category Large accelerated filer
Business Address GEN DE WITTELAAN L11 A3, 2800 MECHELEN, C9, 00000
Mailing Address GEN DE WITTELAAN L11 A3, 2800 MECHELEN, C9, 00000
Phone 3215342900
EIN 000000000

Financial Overview

FY2025

Recent SEC Filings

Form Type Date Filed Document
6-K Foreign company current report March 31, 2026 View on SEC
6-K Foreign company current report March 30, 2026 View on SEC
20-F Foreign company annual report March 26, 2026 View on SEC
6-K Foreign company current report March 24, 2026 View on SEC
6-K Foreign company current report March 17, 2026 View on SEC
6-K Foreign company current report March 10, 2026 View on SEC
6-K Foreign company current report March 6, 2026 View on SEC
6-K Foreign company current report March 5, 2026 View on SEC
6-K Foreign company current report March 4, 2026 View on SEC
6-K Foreign company current report February 23, 2026 View on SEC
View all filings on EDGAR

Annual Reports

20-F March 26, 2026
  • Significant cash position of €3.2 billion provides a runway through 2027.
  • Strategic pivot toward immunology and oncology to streamline operations.
View Analysis

Related Companies

Companies in the same industry (SIC: 2834)

Lipocine Inc.

LPCN Pharmaceutical Preparations

NORTHWEST BIOTHERAPEUTICS INC

NWBO Pharmaceutical Preparations

Jaguar Health, Inc.

JAGX Pharmaceutical Preparations

ARTELO BIOSCIENCES, INC.

ARTL Pharmaceutical Preparations

Cell Source, Inc.

CLCS Pharmaceutical Preparations

Investor Resources

Learn more about SEC filings and how to research public companies.

What is the SEC?

A plain English guide to the Securities and Exchange Commission

Understanding SEC Filings & CIK

How to navigate SEC filings and Central Index Keys

10-K Annual Reports Explained

Everything you need to know about annual reports

S-1 & F-1 IPO Filings

Understanding IPO registration statements

SEC EDGAR Database Guide

How to use the SEC's free filing database
Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.